Circular RNA circHSPA8 Aggravates Metastasis by Acting as a Competitive Inhibitor of miR-195-5p to Upregulate WNT3A

Zhuoying Han1, Xiaojuan Yu2, Chenlong Wang1

  • 1Department of Central Laboratory, The Affiliated Huaian No. 1 People's Hospital, Nanjing Medical University, Huai'an, China.

Insights

Circular RNA HSPA8 (circHSPA8) promotes breast cancer progression by enhancing cell proliferation and metastasis. It acts as a sponge for miR-195-5p, upregulating WNT3A and driving epithelial-mesenchymal transition (EMT).

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Circular RNAs (circRNAs) regulate gene expression and are implicated in cancer progression.
  • Hsa_circ_0024715 (circHSPA8), derived from the HSPA8 gene, is upregulated in breast cancer (BC).
  • The specific role of circHSPA8 in BC tumorigenesis is largely unknown.

Purpose of the Study:

  • To investigate the function and mechanism of circHSPA8 in breast cancer.
  • To determine the association between circHSPA8 expression and BC prognosis.
  • To explore circHSPA8 as a potential therapeutic target.

Main Methods:

  • Quantitative real-time PCR (qPCR) for circHSPA8 expression analysis.
  • Survival analysis in a prospective cohort of BC patients.
  • In vitro cell culture experiments (MCF-7, MDA-MB-231) with circHSPA8 overexpression and knockdown.
  • In vivo metastasis models in mice.

Main Results:

  • High circHSPA8 expression correlates with poor BC prognosis and lymph node metastasis.
  • circHSPA8 overexpression enhances BC cell proliferation and invasion; knockdown reduces these abilities.
  • circHSPA8 promotes epithelial-mesenchymal transition (EMT) by sponging miR-195-5p, leading to WNT3A upregulation.
  • In vivo studies confirm circHSPA8 promotes BC cell intravasation, extravasation, and lung metastasis.

Conclusions:

  • circHSPA8 acts as a crucial oncogenic circRNA in breast cancer.
  • It promotes BC progression and metastasis via the miR-195-5p/WNT3A axis, driving EMT.
  • circHSPA8 represents a potential diagnostic biomarker and therapeutic target for breast cancer.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.1K
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.6K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K